Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth. Click here to learn more ›

Effect of the Melanocortin Receptor Agonist PL8177 on DSS-Induced Colitis in Rats and a Toxicologic Assessment of PL8177 in Beagle Dogs

Scroll to Top